(Q38104471)

28 August 2017

title

Virus-neutralizing antibodies to hepatitis C virus (English)

1 reference

28 August 2017

1 reference

1 reference

1 reference

2

1 reference

28 August 2017

A Wahid

1

0 references

publication date

4 April 2013

1 reference

Journal of Viral Hepatitis

28 August 2017

published in

1 reference

28 August 2017

volume

20

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

369-376

1 reference

Evolving epidemiology of hepatitis C virus

28 August 2017

cites work

1 reference

Limited humoral immunity in hepatitis C virus infection

21 January 2018

1 reference

Entry and replication of recombinant hepatitis C viruses in cell culture

21 January 2018

1 reference

Replication of hepatitis C virus

21 January 2018

1 reference

Characterization of functional hepatitis C virus envelope glycoproteins.

21 January 2018

1 reference

Characterization of the envelope glycoproteins associated with infectious hepatitis C virus

21 January 2018

1 reference

The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule

21 January 2018

1 reference

Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding

21 January 2018

1 reference

Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells

21 January 2018

1 reference

Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

21 January 2018

1 reference

Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein.

21 January 2018

1 reference

Assembly of infectious hepatitis C virus particles

21 January 2018

1 reference

Role of lipid metabolism in hepatitis C virus assembly and entry

21 January 2018

1 reference

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate

21 January 2018

1 reference

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

21 January 2018

1 reference

The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

21 January 2018

1 reference

Role of low-density lipoprotein receptor in the hepatitis C virus life cycle

21 January 2018

1 reference

Hepatitis C virus host cell entry.

21 January 2018

1 reference

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

21 January 2018

1 reference

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants

21 January 2018

1 reference

CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes

21 January 2018

1 reference

Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion

21 January 2018

1 reference

CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry

21 January 2018

1 reference

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

21 January 2018

1 reference

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

21 January 2018

1 reference

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

21 January 2018

1 reference

A genetically humanized mouse model for hepatitis C virus infection

21 January 2018

1 reference

In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

21 January 2018

1 reference

Neutralizing antibody response during acute and chronic hepatitis C virus infection

21 January 2018

1 reference

Humoral immune response in acute hepatitis C virus infection

21 January 2018

1 reference

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection

21 January 2018

1 reference

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

21 January 2018

1 reference

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus

21 January 2018

1 reference

Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion

21 January 2018

1 reference

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

21 January 2018

1 reference

Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment

21 January 2018

1 reference

Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion

21 January 2018

1 reference

Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step

21 January 2018

1 reference

Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein

21 January 2018

1 reference

Hepatitis C virus evasion mechanisms from neutralizing antibodies

21 January 2018

1 reference

Neutralizing antibody response to hepatitis C virus

21 January 2018

1 reference

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

21 January 2018

1 reference

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

21 January 2018

1 reference

Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus

21 January 2018

1 reference

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

21 January 2018

1 reference

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees

21 January 2018

1 reference

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization

21 January 2018

1 reference

Amino acid residue-specific neutralization and nonneutralization of hepatitis C virus by monoclonal antibodies to the E2 protein

21 January 2018

1 reference

The role of neutralizing antibodies in hepatitis C virus infection.

21 January 2018

1 reference

Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate

21 January 2018

1 reference

Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding

21 January 2018

1 reference

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

21 January 2018

1 reference

New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles

21 January 2018

1 reference

Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity

21 January 2018

1 reference

High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.

21 January 2018

1 reference

Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.

21 January 2018

1 reference

Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus

21 January 2018

1 reference

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo

21 January 2018

1 reference

Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection

21 January 2018

1 reference

Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees

21 January 2018

1 reference

Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.

21 January 2018

1 reference

Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization

21 January 2018

1 reference

Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions

21 January 2018

1 reference

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

21 January 2018

1 reference

Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma

21 January 2018

1 reference

Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein

21 January 2018

1 reference

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

21 January 2018

1 reference

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

21 January 2018

1 reference

Production and characterization of HCV particles from serum-free culture

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JVH.12094

1 reference

28 August 2017

1 reference